Buprenorphine HCl
- Product NDC
- 31722-871
- 11-digit product format
- 317220871
- Labeler code
- 31722
- Product ID
- 31722-871_80bd7b21-6679-4dbb-84dd-f755c7a90166
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Buprenorphine HCl
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Labeler
- Camber Pharmaceuticals, Inc.
- Application
- ANDA219401
- Marketing category
- ANDA
- Marketing start
- 2026-01-12
- Substance
- BUPRENORPHINE HYDROCHLORIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Buprenorphine HCl
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUPRENORPHINE HYDROCHLORIDE | 8 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 56W8MW3EN1 |
| Rxcui | 351264, 351265 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 31722-871-30 | Buprenorphine HCl | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 31722-871-30 | 31722087130 | 30 TABLET in 1 BOTTLE (31722-871-30) | 30 tablet | 2026-01-12 | No | No | Historical |